These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 11157146

  • 1. Pilot study of anti-thymocyte globulin plus mycophenolate mofetil in recent-onset diffuse scleroderma.
    Stratton RJ, Wilson H, Black CM.
    Rheumatology (Oxford); 2001 Jan; 40(1):84-8. PubMed ID: 11157146
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate mofetil is an effective and safe option for the management of systemic sclerosis-associated interstitial lung disease: results from the Australian Scleroderma Cohort Study.
    Owen C, Ngian GS, Elford K, Moore O, Stevens W, Nikpour M, Rabusa C, Proudman S, Roddy J, Zochling J, Hill C, Sturgess A, Tymms K, Youssef P, Sahhar J.
    Clin Exp Rheumatol; 2016 Jan; 34 Suppl 100(5):170-176. PubMed ID: 27049330
    [Abstract] [Full Text] [Related]

  • 3. Long-term efficacy and tolerability of mycophenolate mofetil therapy in diffuse scleroderma skin disease.
    Boulos D, Ngian GS, Rajadurai A, Elford K, Stevens W, Proudman S, Owen C, Roddy J, Nikpour M, Youssef P, Hill C, Sahhar J.
    Int J Rheum Dis; 2017 Apr; 20(4):481-488. PubMed ID: 28337853
    [Abstract] [Full Text] [Related]

  • 4. Primary immunosuppression with mycophenolate mofetil and antithymocyte globulin for kidney transplant recipients of a suboptimal graft.
    Grinyó JM, Gil-Vernet S, Seron D, Hueso M, Fulladosa X, Cruzado JM, Moreso F, Fernandez A, Torras J, Riera L, Castelao AM, Alsina J.
    Nephrol Dial Transplant; 1998 Oct; 13(10):2601-4. PubMed ID: 9794567
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease.
    Liossis SN, Bounas A, Andonopoulos AP.
    Rheumatology (Oxford); 2006 Aug; 45(8):1005-8. PubMed ID: 16490756
    [Abstract] [Full Text] [Related]

  • 6. Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation.
    Cantarovich D, Giral-Classe M, Hourmant M, Dantal J, Blancho G, Lerat L, Moreau A, Soulillou JP.
    Nephrol Dial Transplant; 2000 Oct; 15(10):1673-6. PubMed ID: 11007839
    [Abstract] [Full Text] [Related]

  • 7. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM, Gil-Vernet S, Cruzado JM, Caldés A, Riera L, Serón D, Rama I, Torras J.
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [Abstract] [Full Text] [Related]

  • 8. A pilot study of mycophenolate mofetil combined to intravenous methylprednisolone pulses and oral low-dose glucocorticoids in severe early systemic sclerosis.
    Vanthuyne M, Blockmans D, Westhovens R, Roufosse F, Cogan E, Coche E, Nzeusseu Toukap A, Depresseux G, Houssiau FA.
    Clin Exp Rheumatol; 2007 Nov; 25(2):287-92. PubMed ID: 17543155
    [Abstract] [Full Text] [Related]

  • 9. Cyclophosphamide versus mycophenolate mofetil in scleroderma interstitial lung disease (SSc-ILD) as induction therapy: a single-centre, retrospective analysis.
    Shenoy PD, Bavaliya M, Sashidharan S, Nalianda K, Sreenath S.
    Arthritis Res Ther; 2016 Jun 02; 18(1):123. PubMed ID: 27255492
    [Abstract] [Full Text] [Related]

  • 10. Squamous cell carcinomas in 2 patients with diffuse scleroderma treated with mycophenolate mofetil.
    Gulamhusein A, Pope JE.
    J Rheumatol; 2009 Feb 02; 36(2):460-2. PubMed ID: 19208586
    [No Abstract] [Full Text] [Related]

  • 11. Use of mycophenolate mofetil to treat scleroderma-associated interstitial lung disease.
    Zamora AC, Wolters PJ, Collard HR, Connolly MK, Elicker BM, Webb WR, King TE, Golden JA.
    Respir Med; 2008 Jan 02; 102(1):150-5. PubMed ID: 17822892
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy with rituximab and mycophenolate mofetil in systemic sclerosis. A single-centre case series study.
    Fraticelli P, Fischetti C, Salaffi F, Carotti M, Mattioli M, Pomponio G, Gabrielli A.
    Clin Exp Rheumatol; 2018 Jan 02; 36 Suppl 113(4):142-145. PubMed ID: 30277864
    [Abstract] [Full Text] [Related]

  • 13. A prospective observational study of mycophenolate mofetil treatment in progressive diffuse cutaneous systemic sclerosis of recent onset.
    Mendoza FA, Nagle SJ, Lee JB, Jimenez SA.
    J Rheumatol; 2012 Jun 02; 39(6):1241-7. PubMed ID: 22467932
    [Abstract] [Full Text] [Related]

  • 14. Two-year experience with mycophenolate mofetil in patients with scleroderma lung disease: a case series.
    Yilmaz N, Can M, Kocakaya D, Karakurt S, Yavuz S.
    Int J Rheum Dis; 2014 Nov 02; 17(8):923-8. PubMed ID: 24864029
    [Abstract] [Full Text] [Related]

  • 15. Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil.
    Scheinberg P, Nunez O, Wu C, Young NS.
    Br J Haematol; 2006 Jun 02; 133(6):606-11. PubMed ID: 16704434
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
    Talwalkar JA, Angulo P, Keach JC, Petz JL, Jorgensen RA, Lindor KD.
    Am J Gastroenterol; 2005 Feb 02; 100(2):308-12. PubMed ID: 15667487
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil in systemic sclerosis-associated interstitial lung disease.
    Koutroumpas A, Ziogas A, Alexiou I, Barouta G, Sakkas LI.
    Clin Rheumatol; 2010 Oct 02; 29(10):1167-8. PubMed ID: 20532938
    [Abstract] [Full Text] [Related]

  • 18. Long-term experience of mycophenolate mofetil for treatment of diffuse cutaneous systemic sclerosis.
    Le EN, Wigley FM, Shah AA, Boin F, Hummers LK.
    Ann Rheum Dis; 2011 Jun 02; 70(6):1104-7. PubMed ID: 21378404
    [Abstract] [Full Text] [Related]

  • 19. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Jun 02; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 20. Early onset neutropenia after mycophenolate mofetil in systemic sclerosis.
    Cuomo G, Abignano G, Valentini G.
    Rheumatol Int; 2009 Oct 02; 29(12):1529-30. PubMed ID: 19247660
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.